Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT.

Ditschkowski M, Haferlach C, Schulte C, Trenschel R, Beelen D W

Bone Marrow Transplant. 2009 Aug;44(4):265-6. doi: 10.1038/bmt.2009.8. Epub 2009 Feb 23.

Abstract

摘要

相似文献

Bone Marrow Transplant. 2009 Aug;44(4):265-6. doi: 10.1038/bmt.2009.8. Epub 2009 Feb 23.

Gan To Kagaku Ryoho. 2003 Mar;30(3):427-30.

Pharmacotherapy. 2005 Mar;25(3):325-34. doi: 10.1592/phco.25.3.325.61593.

Stem Cells. 1999;17(1):9-17. doi: 10.1002/stem.170009.

Leuk Res. 2009 Jun;33(6):860-1. doi: 10.1016/j.leukres.2008.09.021. Epub 2008 Nov 1.

Bone Marrow Transplant. 2006 Mar;37(6):575-82. doi: 10.1038/sj.bmt.1705284.

Eur J Haematol. 2007 Aug;79(2):170-3. doi: 10.1111/j.1600-0609.2007.00890.x. Epub 2007 Jun 28.

Leukemia. 2003 Feb;17(2):458-60. doi: 10.1038/sj.leu.2402811.

Am J Hematol. 2007 Aug;82(8):758-60. doi: 10.1002/ajh.20882.

Haematologica. 2006 Aug;91(8):1145-6. Epub 2006 Jul 25.

Blood Adv. 2023 May 23;7(10):1976-1986. doi: 10.1182/bloodadvances.2022007941.

Biol Blood Marrow Transplant. 2010 Jul;16(7):1025-31. doi: 10.1016/j.bbmt.2010.02.014. Epub 2010 Feb 21.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。